Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bromodomain inhibitors for androgen receptor-driven cancers

Bromodomain inhibitors for androgen receptor-driven cancers

US Patent 11801243 · Granted Oct 31, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibiting CREB binding protein (CBP)2025
Inhibiting cyclic AMP-responsive element-binding protein (CREB)2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025
Activating pyruvate kinase R2024
Activating pyruvate kinase R2024
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators2024
Treating sickle cell disease with a pyruvate kinase R activating compound2024
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2024
Treating sickle cell disease with a pyruvate kinase R activating compound2024
Activating pyruvate kinase R2023
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors2023
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators2023